# NeoGenomics, Inc. (NEO): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/neo for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Medical - Diagnostics & Research
- Exchange: NASDAQ · Trading currency: USD

NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers. NeoGenomics' advanced testing capabilities encompass cytogenetics, which examines normal and abnormal chromosomes in relation to dise...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $16.59 USD |
| Market Cap | $2.16B |
| P/E (TTM) | 110.60 |
| EPS (TTM) | $0.15 |
| 52-Week Range | $7.07 – $20.15 |
| Dividend Yield (TTM) | — |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | — |
| Annual Dividend (TTM) | — /share |
| Annual Dividend (Forward) | — /share |
| Frequency | Irregular |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | — / — / — / — |
| Payout Ratio (EPS, TTM) | — |
| Payout Ratio (FCF, TTM) | — |
| Payout Ratio (EPS, forward dividend) | — |
| Payout Ratio (FCF, forward dividend) | — |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2020-12-17 | $0.4000 | 2020-12-30 |

Full history: https://www.dividenddata.com/stocks/neo/dividend

## Frequently Asked Questions

### What does NeoGenomics, Inc. do?

NeoGenomics, Inc. (NEO) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is NEO's market cap?

NeoGenomics, Inc. (NEO) has a market capitalization of approximately $2.16 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does NEO pay a dividend?

No, NeoGenomics, Inc. (NEO) is not currently paying a dividend. Its last ex-dividend date was December 17, 2020 ($0.40 per share), and no payment has been declared since. The full historical payment record is on the Dividend tab.

### How often did NEO pay dividends?

NeoGenomics, Inc. paid dividends irregular until 2020; nothing has been declared since. Each historical ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is NEO's payout ratio?

NeoGenomics, Inc.'s payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/neo
- Dividend history & safety: https://www.dividenddata.com/stocks/neo/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/neo/earnings
- Financial statements: https://www.dividenddata.com/stocks/neo/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/neo/valuation
- Peer comparison: https://www.dividenddata.com/stocks/neo/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.